Lidia W Szczepanski

Emerging Evidence for the Use of Antidiabetic Drugs, Glucagon-like Peptide 1 Receptor Agonists, for the Treatment of Alzheimer’s Disease

I. Colin, A. Gérard, J. Elosegi, 2023, TouchREVIEWS in endocrinology.